Enbio AG Focuses To Penetrate The Indian Market With It's World

Posted By: Sachin MurdeshwarAugust 4, 2023

NATIONAL, 4 AUGUST, 2023 (GPN) – Enbio AG, a global giant in the autoclave sector, has set its sights on the Indian healthcare market with its best-in-class Swiss-designed sterilizers. With an established presence in 50 countries, Enbio is now introducing its innovative and highly advanced B Class Autoclaves to India, capable of sterilizing microsurgical instruments within an astounding 7-9 minutes. Enbio India has charted an ambitious plan to capture a substantial market share within the next two-three years.

“Enbio is already establishing its presence across all major metro cities in India, ensuring that its cutting-edge products are readily available to a wide range of healthcare facilities. We want to focus on the Indian market and would invest to expand our business operations here,” said Karolina Matracka, Global Sales and Marketing Director of Enbio Group AG.

“We are actively expanding our sales and service network throughout the country to provide comprehensive coverage and support for customers nationwide. With these expansion plans, Enbio aims to strengthen its position in the Indian autoclave market and cater to the increasing demand for fast, efficient, and reliable sterilization solutions,” added Karolina Matracka.

Autoclave technology has seen remarkable advancements in recent years, revolutionizing sterilization processes in various industries, particularly healthcare. As per the industry estimates the Autoclaves Market size exceeded USD 2.2 billion in 2020 and is expected to witness more than 9.7% CAGR between 2021 and 2027. The global steam autoclave market size is estimated to be worth USD 3.18 billion by 2028. The pandemic has given a big push to the way India used to deal with infection control. Medical practitioners now place a greater emphasis on infection control practices in hospitals and clinics to ensure patient safety and prevent nosocomial infections. The exploration and the need to deploy advanced sterilization technologies to ensure a higher level of disinfection and protection against pathogens have gained new momentum with the rising demand.

Enbio, being a key player in this market, has leveraged its expertise to offer innovative autoclave technologies and services. Enbio’s Class B autoclave sterilizers are designed to address the pressing issue of nosocomial infections, providing flash sterilization cycles that significantly reduce sterilization time. This empowers healthcare professionals to respond swiftly and efficiently during critical moments, enabling emergency surgeries without unnecessary delays and ultimately improving patient outcomes and safety. So far, Enbio has garnered a global community of more than 38,000 users who rely on their autoclaves to ensure the complete safety of their clients and patients.

“The currently available sterilization options often prove time-consuming, leading to significant challenges during emergencies,” said Prashant Arer, India-Head of Enbio. “Doctors are forced to wait for sterilized instruments, causing potential delays in critical surgeries. In some cases, surgeries may even need to be postponed due to the unavailability of sterile instruments. Overall, the Indian healthcare sector, especially users of micro-surgical instruments such as dentists and ophthalmologists, requires autoclaves that are fast, affordable, quality-certified, compact, portable, swift, silent, and easy to use.”

Enbio has been at the forefront of integrating digital controls and automation into their autoclaves, ensuring precise and consistent sterilization cycles. The incorporation of digital displays, touchscreens, and programmable settings reduces the likelihood of human error and ensures optimal sterilization conditions. Additionally, Enbio’s autoclaves utilize advanced alloys and materials, enhancing their durability and resistance to corrosion, resulting in longer service life and reduced maintenance requirements.

“The incorporation of smart sensors and monitoring systems in Enbio autoclaves enables real-time detection of pressure, temperature, and steam levels, ensuring adherence to specified parameters and providing alerts in case of deviations. Moreover, Enbio autoclaves come equipped with improved safety features, including automatic pressure release mechanisms and door-locking systems that prevent accidental opening during operation,” emphasized Prashanth Arer.

Enbio sterilizers stand out from the competition due to their exceptional features and benefits. Compared to typical class/vacuum autoclaves, Enbio’s sterilizers are up to four times faster, six times smaller and three times lighter, while maintaining exceptional work efficiency. In emergency situations, Enbio can sterilize unwrapped instruments for immediate use in just 7 minutes, providing healthcare professionals with essential tools when urgently needed. The affordability of Enbio’s B Class sterilizers sets them apart from traditional autoclaves, allowing customers to acquire two Enbio machines for the price of one competitor’s machine. Additionally, Enbio’s commitment to compliance with all medical norms and regulations ensures safety and peace of mind for both healthcare professionals and their clients.

With its unmatched combination of speed, efficiency, safety, and affordability, Enbio is poised to revolutionize the sterilization landscape in India and make a significant impact on the Indian healthcare sector.

About Enbio

Enbio, a Swiss medical autoclave manufacturer, is part of a global capital group with a total turnover exceeding 200 million Euro annually. Enbio DNA originates from over 30 years of experience in biotechnology and industrial hydroponics, where quality of sterilization is a critical success factor. Our expanding worldwide distribution network is supported by logistics and service centers located in Europe and the United States. The company also plans to set up a logistic center in India in the coming years.